Plain-English translation of NCT03987763 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing , a new topical cream, to see how well it works and how safe it is for children with moderate to severe plaque psoriasis. The researchers will measure how much of the medication enters the bloodstream and whether it affects your child's adrenal hormones. About 45 children ages 6 to 17 will participate, split into two age groups.
Psoriasis is a challenging condition for children, and doctors need to make sure topical treatments are both effective and safe, especially when it comes to potential effects on the body's hormone system.
You likely qualify if…
You likely don't qualify if…
Your child will apply the medication to their psoriasis plaques once daily for 8 weeks. You'll attend multiple visits at the research center for check-ups, blood tests (including a hormone test at the start), and assessments of how the skin is responding. The study includes a screening visit, a baseline visit, and follow-up visits throughout the 8-week treatment period.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States